MaxCyte, Inc. Presents Large Scale Flow Electroporation for Process Development and Bioproduction at CHI’s 2013 BioProcessing Summit

Published: Aug 19, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MaxCyte, Inc., the pioneer in scalable, high performance cell transfection systems, is hosting a series of events at Cambridge Health Institute’s BioProcessing Summit to be held August 19-23, 2013, at the Renaissance Boston Waterfront Hotel in Boston, MA. MaxCyte will present data in a scientific podium presentation emphasizing the use of MaxCyte flow electroporation for the rapid production of antibodies and antibody-like molecules at extremely high titers, as well as high-efficiency downstream generation of stable cell lines.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news